Sign in
4

Changes in Ownership

Cogent Biosciences, Inc. Filed Acc 0000899243-21-011695

Options or other derivatives

  • Director acquired 22,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Shegog Todd Director 2021-03-11 Grant or award · Stock Option (Right to Buy) +22,500 22,500 D
Loading xslF345X03/doc4.xml…